Concepedia

Transfection Process Development

Transfection Process Development is a methodological framework within biopharmaceutical process development that systematically optimizes the delivery of genetic material into host cells to achieve scalable, efficient, and reproducible gene expression for therapeutic or research applications.

77

Publications

9.5K

Citations

349

Authors

129

Institutions

Publications per year

2017–2026

10

Parents

Publications

77

Efficient selection for high-expression transfectants with a novel eukaryotic vector

Hitoshi Niwa, Ken‐ichi Yamamura, Jun‐ichi Miyazaki · Gene · 1991 · 5.2K citations

, , +15

New procedure for DNA transfection with polycation and dimethyl sulfoxide.

S Kawai, M Nishizawa · Molecular and Cellular Biology · 1984 · 483 citations · Full text

, , +17

New Procedure for DNA Transfection with Polycation and Dimethyl Sulfoxide

Sadaaki Kawai, Makoto Nishizawa · Molecular and Cellular Biology · 1984 · 218 citations

, , +17

Preparation of primary amine-modified gold nanoparticles and their transfection ability into cultivated cellsElectronic Supplementary Information (ESI) available: A TEM image of the complex at a w/w ratio of 11. See http://www.rsc.org/suppdata/cc/b4/b406189f/

Takuro Niidome, Kanako Nakashima, Hironobu Takahashi et al. · Chemical Communications · 2004 · 201 citations

, , +14

Polyethylenimine, a cost‐effective transfection reagent

Christina Ehrhardt, Mirco Schmolke, Andreas Matzke et al. · Signal Transduction · 2006 · 168 citations

, , +12

1–5 of 77

Authors

349

  1. VC
    Valentina Ciccarone

    MacroGenics (United States), United States

    2 publications · 40 citations

    2

    h-index

  2. PH
    Pamela Hawley‐Nelson

    National Cancer Institute, United States

    2 publications · 40 citations

    2

    h-index

  3. YD
    Yves Durocher

    National Research Council Canada, Canada

    2 publications · 137 citations

    2

    h-index

  4. PS
    Peter Salmon

    University of Liverpool, United Kingdom

    2 publications · 155 citations

    2

    h-index

  5. MD
    Maria D. Hougland

    Eli Lilly (United States), United States

    2 publications · 95 citations

    2

    h-index

1–5 of 349

Institutions

129

  1. Merck & Co., Inc., Rahway, NJ, USA (United States)

    Rahway, United States

    3 h-index

    19 publications

    1K citations

  2. University of California, Davis

    Davis, United States

    2 h-index

    4 publications

    228 citations

  3. AstraZeneca (Sweden)

    Södertälje, Sweden

    2 h-index

    7 publications

    284 citations

  4. Eli Lilly (United States)

    Indianapolis, United States

    2 h-index

    8 publications

    417 citations

  5. The University of Queensland

    Brisbane, Australia

    2 h-index

    10 publications

    240 citations

  6. Heidelberg University

    Heidelberg, Germany

    2 h-index

    2 publications

    164 citations

  7. Kanagawa Academy of Science and Technology

    Kawasaki, Japan

    2 h-index

    3 publications

    64 citations

  8. The University of Tokyo

    Tokyo, Japan

    2 h-index

    4 publications

    1.4K citations

1–8 of 129

Venues

  1. Biotechnology and Bioengineering

    5 publications · 259 citations

    5

    h-index

  2. BioTechniques

    5 publications · 150 citations

    5

    h-index

  3. Methods

    3 publications · 178 citations

    3

    h-index

  4. PubMed

    Repository · 3 publications · 91 citations

    3

    h-index

  5. Analytical Biochemistry

    2 publications · 56 citations

    2

    h-index

1–5